BioVaxys Technology Corp. (CSE: BIOV)
Canada
· Delayed Price · Currency is CAD 0.0550
-0.0100 (-15.38%)
Sep 25, 2024, 12:38 PM EDT
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 16.64 million as of September 26, 2024. Its market cap has increased by 181.08% in one year.
Market Cap
16.64M
Enterprise Value
16.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 16.64M, a decrease of -38.49%. That is a compound annual growth rate of -11.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2024 | 16.64M | 129.36% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | 14.32M | -47.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries Inc. | 3.31B |
| Trulieve Cannabis Corp. | 2.99B |
| Cresco Labs Inc. | 789.35M |
| Planet 13 Holdings Inc. | 269.89M |
| Ayr Wellness Inc. | 256.51M |
| Grown Rogue International Inc. | 202.27M |
| Jushi Holdings Inc. | 145.61M |
| iAnthus Capital Holdings, Inc. | 99.40M |